Abstract

The CDC denies that COVID-19 injections from Pfizer, Moderna, or Novavax can cause magnetism, even at the site of the injection. The CDC claims that the three ferromagnetic metals consisting of iron, cobalt, and nickel, and the rare earth chemicals used in magnets cerium, hafnium, lanthanum, gadolinium, and erbium are not in the US approved injectables. However, a 2024 study using inductively coupled plasma-mass spectrometry (ICP-MS), detected all these and many other undeclared elements in lots of Pfizer, Moderna, and five other brands of COVID-19 injectables. By contrast with the CDC denials, James Giordano, who has become Director of the Defense Advanced Research Projects Agency (DARPA), has argued since 2018 that the human brain is the battleground for DARPA’s “disruptive technologies” of warfare using magnetic nanoparticles delivered “intranasally, intravenously, or intraorally” all without surgery to achieve “mind-control” by adjusting the frequencies, power, and directionality of the electromagnetic forces. The science of magnetofection is little known but has been under development for decades. We explain it here and ask, could militarized experimentation with magnetic nanoparticles be involved in causing the documented outcomes of proteinaceous clotting, cardio-vascular conditions, strokes, new autoimmune diseases, unprecedented rapidly developing “prion diseases”, “turbo” cancers, and sudden deaths many of these occurring in otherwise young and healthy recipients of the experimental COVID-19 injectables? The research discussed in this paper implies that an affirmative answer cannot be ruled out.

References

1. J. W. Oller and C. A. Shaw, “From superficial damage to invasion of the nucleosome: ranking of morbidities by the biosemiotic depth hypothesis,” International Journal of Sciences, vol. 8, no. 06, pp. 51–73, Jun. 2019, https://doi.org/10.18483/ijSci.2069.
2. D. Santiago and J. W. Oller, “Abnormal clots and all-cause mortality during the pandemic experiment: five doses of COVID-19 vaccine are evidently lethal to nearly all Medicare participants,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 1, pp. 847–890, Apr. 2023, https://doi.org/10.56098/ijvtpr.v3i1.73.
3. K. D. Nance and J. L. Meier, “Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines,” ACS Cent. Sci., vol. 7, no. 5, pp. 748–756, May 2021, https://doi.org/10.1021/acscentsci.1c00197.
4. M. C. Roco and W. S. Bainbridge, “Converging Technologies for Improving Human Performance Nanotechnology , Biotechnology , Information Technology, and Cognitive Science.” National Science Foundation/Documents Report, 2002. Accessed: Jun. 27, 2025. [Online]. Available: https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/bioecon-%28%23%20023SUPP%29%20NSF-NBIC.pdf
5. C. Lee, B.-H. Koo, C.-B. Chae, and R. Schober, “The Internet of bio-nano things in blood vessels: System design and prototypes,” Journal of Communications and Networks, vol. 25, no. 2, pp. 222–231, Apr. 2023, https://doi.org/10.23919/JCN.2023.000001.
6. I. Akyildiz, M. Pierobon, S. Balasubramaniam, and Y. Koucheryavy, “The internet of Bio-Nano things,” IEEE Communications Magazine, vol. 53, p. 32, Apr. 2015, https://doi.org/10.1109/MCOM.2015.7060516.
7. J. Giordano, “The Brain as the Battlefield of the Future: Modern War Speaker Institute Series at the US Military Academy at West Point.” Accessed: May 03, 2025. [Online]. Available: https://www.google.com/search?client=firefox-b-1-d&channel=entpr&q=James+Giordano%2C+N%23#fpstate=ive&vld=cid:17be7141,vid:N02SK9yd60s,st:0
8. J. Giordano, The Battle for Your Mind: Neuroscience, Technology/AI & the OODA Loop w/ James Giordano, PhD | Flow, (Aug. 01, 2023). Accessed: May 02, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=1cPWJfjXu7M
9. J. Giordano, “DARPA’s N3: The Future of Non-Surgical Brain Interfaces,” Institute for Biodefense Research. Accessed: Apr. 11, 2025. [Online]. Available: https://biodefenseresearch.org/darpas-n3-the-future-of-non-surgical-brain-interfaces/
10. J. Giordano and Defense Media Activity, “James Giordano,” Institute for National Strategic Studies. Accessed: May 28, 2025. [Online]. Available: https://inss.ndu.edu/Media/Biographies/Article-View/Article/4044640/james-giordano/https%3A%2F%2Finss.ndu.edu%2FMedia%2FBiographies%2FArticle-View%2FArticle%2F4044640%2Fjames-giordano%2F
11. J. A. Thorp, K. E. Thorp, E. K. Lile, and J. Viglione, “Unexpected magnetic attraction: Evidence for an organized energy field in the human body,” TheGMS, vol. 2, no. 4, pp. 1–15, Jul. 2021, https://doi.org/10.46766/thegms.pubheal.21071202.
12. T. Tuuminen, P. J. Suominen, and M. Ahonen, “Clinical manifestations of iatrogenic magnetism in subjects after receiving COVID-19 injectables: case report series,” International Journal of Innovative Research in Medical Science, vol. 10, no. 06, pp. 207–210, Jun. 2025, doi: 10.23958/ijirms/vol10-i06/2081.
13. L. Diblasi, M. Monteverde, D. Nonis, and M. Sangorrín, “At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with Precise ICP-MS,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1367–1393, Oct. 2024, doi: 10.56098/mt1njj52.
14. A. S. Ulrich, “No Nanobots in Vaccines Just Lipids on the Loose: Commentary on Lee and Broudy (2024), ‘Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructs in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitundinal Study,’” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, p. 1244.1-1244.10, Sep. 2024, https://doi.org/10.56098/7hsjff81.
15. R. M. Davidson, D. Broudy, S. Yanowitz, D. Santiago, and J. John W. Oller, “True or False? At Least 55 Undeclared Chemical Elements Have Been Detected by ICP-MS in COVID-19 ‘Vaccines,’” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, Art. no. 2, Dec. 2024, https://doi.org/10.56098/98sw8e86.
16. D. Speicher, J. Rose, L. Gutschi, D. Wiseman, and K. McKernan, DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events. 2023. [Online]. Available: https://www.researchgate.net/publication/374870815_Speicher_DJ_et_al_DNA_fragments_detected_in_COVID-19_vaccines_in_Canada_DNA_fragments_detected_in_monovalent_and_bivalent/figures
17. M. Gutschi, Quality issues with mRNA COVID vaccine production, (Nov. 02, 2022). Accessed: Nov. 02, 2022. [Online Video]. Available: https://www.bitchute.com/video/muB0nrznCAC4/
18. G. Pólya, “Über den zentralen Grenzwertsatz der Wahrscheinlichkeitsrechnung und das Momentenproblem [About the central limit theorem of the probability calculation and the moment problem],” Mathematische Zeitschrift, vol. 8, no. 3–4, pp. 171–181, 1920.
19. L. Le Cam, “The Central Limit Theorem around 1935,” Statistical Science, vol. 1, no. 1, pp. 78–91, 1986.
20. M. N. Mead, S. Seneff, J. Rose, R. Wolfinger, P. A. McCullough, and N. Hulscher, “COVID-19 modified mRNA ‘vaccines’: lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, part 2,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1275–1344, Aug. 2024, https://doi.org/10.56098/w66wjg87.
21. M. N. Mead et al., “COVID-19 modified mRNA ‘vaccines’: lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, part 1,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1112–1178, Jun. 2024, https://doi.org/10.56098/fdrasy50.
22. J. W. Oller and D. Santiago, “All cause mortality and COVID-19 injections: evidence from 28 weeks of Public Health England ‘COVID-19 vaccine surveillance reports,’” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 2, pp. 301–319, May 2022, https://doi.org/10.56098/ijvtpr.v2i2.42.
23. D. Santiago, “Playing Russian Roulette with every COVID-19 injection: the deadly global game,” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 2, pp. 619–650, Oct. 2022, https://doi.org/10.56098/ijvtpr.v2i2.36.
24. D. Santiago, “A partial answer to the question posed by David A. Hughes, PhD, in the article: ‘What is in the so-called COVID-19 “vaccines”? Part 1: evidence of a global crime against humanity,’” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 2, pp. 587–594, Sep. 2022, https://doi.org/10.56098/ijvtpr.v2i2.56.
25. Johns Hopkins Bloomberg School of Public Health, World Economic Forum, and Bill and Melinda Gates Foundation, “Event 201, a pandemic exercise to illustrate preparedness efforts.” Accessed: Dec. 09, 2021. [Online]. Available: https://centerforhealthsecurity.org/event201/
26. S. E. Peters et al., “Menstrual abnormalities strongly associated with proximity to COVID-19 vaccinated individuals,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1435–1461, Dec. 2024, https://doi.org/10.56098/tp99wn15.
27. K. A. Beattie, “Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries,” 2021, [Online]. Available: https://www.researchgate.net/publication/356248984_Worldwide_Bayesian_Causal_Impact_Analysis_of_Vaccine_Administration_on_Deaths_and_Cases_Associated_with_COVID-19_A_BigData_Analysis_of_145_Countries
28. K. A. Beattie, Impacts on Death & Disease by COVID-19 Remedies. Dallas TX: International Journal of Vaccine Theory, Practice, and Research, 2024. [Online]. Available: TBA
29. D. Rancourt, “Nature of the COVID-era public health disaster in the USA from all-cause mortality and socio-geo-economic and climatic data.” Accessed: Sep. 07, 2022. [Online]. Available: https://vaccinesafety.info/2022/02/25/2021-10-25-nature-of-the-covid-era-public-health-disaster-in-the-usa-from-all-cause-mortality-and-socio-geo-economic-and-climatic-data-denis-rancourt-2/, https://denisrancourt.ca/entries.php?id=107&name=2021_10_25_nature_of_the_covid_era_public_health_disaster_in_the_usa_from_all_cause_mortality_and_socio_geo_economic_and_climatic_data
30. D. Rancourt, M. Baudin, and J. Mercier, Staggering 17 million deaths after Covid jab rollouts, (Nov. 19, 2023). Accessed: Dec. 14, 2023. [Online Video]. Available: https://www.bitchute.com/video/jJg7E2ajQN2J/
31. J. J. Liu, C. M. Bell, J. J. Matelski, A. S. Detsky, and P. Cram, “Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study,” BMJ, vol. 359, p. j4619, Oct. 2017, https://doi.org/10.1136/bmj.j4619.
32. H. G. C. Van Spall and S. Whitelaw, “Medical publishing under review,” Eur. Heart J., vol. 42, no. 7, pp. 723–725, Feb. 2021, https://doi.org/10.1093/eurheartj/ehaa856.
33. T. Torgerson et al., “Ten Years Later: A Review of the US 2009 Institute of Medicine Report on Conflicts of Interest and Solutions for Further Reform,” BMJ Evid.-Based Med., vol. 27, no. 1, pp. 46–54, Feb. 2022, https://doi.org/10.1136/bmjebm-2020-111503.
34. J. A. Teixeira da Silva, J. Dobranszki, R. H. Bhar, and C. T. Mehlman, “Editors Should Declare Conflicts of Interest,” J. Bioethical Inq., vol. 16, no. 2, pp. 279–298, Jun. 2019, https://doi.org/10.1007/s11673-019-09908-2.
35. A. Makarem et al., “Conflict of interest in the peer review process: A survey of peer review reports,” PLoS One, vol. 18, no. 6, p. e0286908, Jun. 2023, https://doi.org/10.1371/journal.pone.0286908.
36. A. Lundh, K. Rasmussen, L. Ostengaard, I. Boutron, L. A. Stewart, and A. Hrobjartsson, “Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially,” J. Clin. Epidemiol., vol. 120, pp. 104–115, Apr. 2020, https://doi.org/10.1016/j.jclinepi.2019.12.005.
37. C. B. Korfitsen, C. H. Nejstgaard, A. Hrobjartsson, I. Boutron, L. Bero, and A. Lundh, “Peer reviewers’ conflicts of interest in biomedical research: scoping review,” BMJ Evid.-Based Med., vol. 30, no. 2, pp. 104–117, Apr. 2025, https://doi.org/10.1136/bmjebm-2024-112967.
38. C. M. Faggion, “Watching the watchers: A report on the disclosure of potential conflicts of interest by editors and editorial board members of dental journals,” Eur. J. Oral Sci., vol. 129, no. 6, Dec. 2021, https://doi.org/10.1111/eos.12823.
39. R. F. J. Kennedy, The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health. Skyhorse, 2021. [Online]. Available: https://www.amazon.com/s?k=the+real+anthony+fauci+robert+f+kennedy+jr+book&crid=5ZXMNU0B59V
40. C. Plank, O. Zelphati, and O. Mykhaylyk, “Magnetically enhanced nucleic acid delivery. Ten years of magnetofectionProgress and prospects,” Advanced Drug Delivery Reviews, vol. 63, no. 14, pp. 1300–1331, Nov. 2011, https://doi.org/10.1016/j.addr.2011.08.002.
41. C. C. Berry and A. S. G. Curtis, “Functionalisation of magnetic nanoparticles for applications in biomedicine,” J. Phys. D-Appl. Phys., vol. 36, no. 13, pp. R198–R206, Jul. 2003, https://doi.org/10.1088/0022-3727/36/13/203.
42. S. Qian et al., “Association analyses between urinary concentrations of multiple trace elements and gastric precancerous lesions and gastric cancer in Anhui province, eastern China,” Frontiers in Public Health, vol. 12, p. 1423286, 2024.
43. Y. Zhu et al., “Associated effects of blood metal(loid) exposure and impaired glucose metabolism in patients with gastric precancerous lesions or gastric cancer,” Biometals, vol. 38, no. 3, pp. 887–902, Jun. 2025, https://doi.org/10.1007/s10534-025-00684-8.
44. K. Widder, P. Marino, R. Morris, D. Howard, G. Poore, and A. Senyei, “Selective targeting of magnetic albumin microspheres to the Yoshida Sarcoma --- ultrastructural evaluation of microsphere disposition,” EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, vol. 19, no. 1, pp. 141-+, 1983, https://doi.org/10.1016/0277-5379(83)90409-1.
45. J. Larionova, Y. Guari, S. Sene, and G. Félix, “Chapter 331 - Luminescent lanthanide-based single-molecule magnets,” in Handbook on the Physics and Chemistry of Rare Earths, vol. 64, J.-C. G. Bunzli and S. M. Kauzlarich, Eds., in Handbook on the Physics and Chemistry of Rare Earths: Including Actinides, vol. 64. , Elsevier, 2023, pp. 93–173. https://doi.org/10.1016/bs.hpcre.2023.10.003.
46. M. Cruz-Acuna, J. R. Halman, K. A. Afonin, J. Dobson, and C. Rinaldi, “Magnetic nanoparticles loaded with functional RNA nanoparticles,” Nanoscale, vol. 10, no. 37, pp. 17761–17770, Oct. 2018, https://doi.org/10.1039/c8nr04254c.
47. K. D. Nance and J. L. Meier, “Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines,” ACS Cent Sci, vol. 7, no. 5, pp. 748–756, May 2021, https://doi.org/10.1021/acscentsci.1c00197.
48. D. Santiago, “A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1345–1366, Oct. 2024, https://doi.org/10.56098/5azda593.
49. D. Lisse et al., “Engineered ferritin for magnetogenetic manipulation of proteins and organelles inside living cells,” Adv. Mater., vol. 29, no. 42, p. 1700189, Nov. 2017, https://doi.org/10.1002/adma.201700189.
50. M. Hernandez-Morales et al., “Electrophysiological mechanisms and validation of ferritin-based magnetogenetics for remote control of neurons,” J. Neurosci., vol. 44, no. 30, p. e1717232024, Jul. 2024, https://doi.org/10.1523/JNEUROSCI.1717-23.2024.
51. M. Hernandez-Morales, V. Han, R. H. Kramer, and C. Liu, “Evaluating methods and protocols of ferritin-based magnetogenetics,” iScience, vol. 24, no. 10, p. 103094, Oct. 2021, https://doi.org/10.1016/j.isci.2021.103094.
52. C. A. Shaw, Neural Dynamics of Neurological Disease. John Wiley & Sons, Inc., 2017. https://doi.org/10.1002/9781118634523.refs.
53. M. Babincova, S. Durdik, N. Babincova, P. Sourivong, and P. Babinec, “Application of cationized magnetoferritin for magnetic field-assisted delivery of short interfering RNA in vitro,” Lasers Med. Sci., vol. 33, no. 8, pp. 1807–1812, Nov. 2018, https://doi.org/10.1007/s10103-018-2547-0.
54. Y.-C. Chung, Y.-S. Chen, and S.-H. Lin, “Enhancement for gene transfection of low-descent-velocity bacteria using magnetic attraction in electroporation chip,” Sens. Actuator B-Chem., vol. 213, pp. 261–267, Jul. 2015, https://doi.org/10.1016/j.snb.2015.02.097.
55. C. Dahmani et al., “Rotational magnetic pulses enhance the magnetofection efficiency in vitro in adherent and suspension cells,” J. Magn. Magn. Mater., vol. 332, pp. 163–171, Apr. 2013, https://doi.org/10.1016/j.jmmm.2012.12.029.
56. E. Stride, C. Porter, A. G. Prieto, and Q. Pankhurst, “Enhancement of Microbubble Mediated Gene Delivery by Simultaneous Exposure to Ultrasonic and Magnetic Fields,” Ultrasound Med. Biol., vol. 35, no. 5, pp. 861–868, May 2009, https://doi.org/10.1016/j.ultrasmedbio.2008.11.010.
57. O. Mykhaylyk, Y. S. Antequera, D. Vlaskou, and C. Plank, “Generation of magnetic nonviral gene transfer agents and magnetofection in vitro,” Nat. Protoc., vol. 2, no. 10, pp. 2391–2411, 2007, https://doi.org/10.1038/nprot.2007.352.
58. S. Prijic et al., “Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field,” J. Membr. Biol., vol. 236, no. 1, pp. 167–179, Jul. 2010, https://doi.org/10.1007/s00232-010-9271-4.
59. Y.-K. Kim et al., “PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier,” Journal of Drug Targeting, vol. 24, no. 5, pp. 457–467, May 2016, https://doi.org/10.3109/1061186X.2015.1087527.
60. M. Uzhytchak et al., “The use of pulsed magnetic fields to increase the uptake of iron oxide nanoparticles by living cells,” Appl. Phys. Lett., vol. 111, no. 24, p. 243703, Dec. 2017, https://doi.org/10.1063/1.5007797.
61. S. D. Shirsat et al., “Endosomal escape in magnetic nanostructures: Recent advances and future perspectives,” Mater. Today Adv., vol. 22, p. 100484, Jun. 2024, https://doi.org/10.1016/j.mtadv.2024.100484.
62. Mito, “What are Mitochondria and Why They Matter - MitoCanada.” Accessed: May 02, 2025. [Online]. Available: https://mitocanada.org/what-are-mitochondria/
63. Kevin McKernan [@Kevin_McKernan], “Update https://t.co/E4NDjBF0F8,” Twitter. Accessed: Jun. 09, 2025. [Online]. Available: https://x.com/Kevin_McKernan/status/1931351886310834369
64. M. Playne, “URGENT WARNING - MRIs and VACCINE-INDUCED MAGNETISM,” Not On The Beeb. Accessed: May 14, 2025. [Online]. Available: https://www.notonthebeeb.co.uk/post/gp-urgent-warning
65. M. Playne and Not on the BEEB, “Vaccine Induced Magnetism,” Not on the Beeb. Accessed: Nov. 08, 2024. [Online]. Available: https://www.notonthebeeb.co.uk/magnetism
66. M. Playne and Not on the BEEB, “Magnetism Compilation,” Not On The Beeb. Accessed: Apr. 09, 2025. [Online]. Available: https://www.notonthebeeb.co.uk/magnet-challenge-compilation
67. D. Funke, “Fact check: COVID-19 vaccines aren’t magnetic,” USA TODAY. Accessed: Apr. 25, 2025. [Online]. Available: https://www.usatoday.com/story/news/factcheck/2021/06/21/fact-check-covid-19-vaccines-arent-magnetic/7698556002/
68. D. Broudy and V. Kyrie, “Syllogistic reasoning demystifies evidence of COVID-19 vaccine constituents,” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 1, pp. 149–171, Dec. 2021, https://doi.org/10.56098/ijvtpr.v2i1.32.
69. P. McMillan, D. Kell, and Vejon Health, What If Clots Are the Missing Link?, (May 24, 2025). Accessed: May 27, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=PdGmfxh-zdg
70. P. McMillan, Can Spike Protein Trigger a Mad Cow Disease Mimic?, (Apr. 24, 2025). Accessed: Apr. 25, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=l8AsjEjgakk
71. Wolfram Research, Inc., “Magnetic Type for all the elements in the Periodic Table.” Accessed: Apr. 29, 2025. [Online]. Available: https://periodictable.com/Properties/A/MagneticType.v.html
72. Center for Nondestructive Evaluation, Iowa State University, “Nondestructive Evaluation Physics : Magnetism.” Accessed: Apr. 28, 2025. [Online]. Available: https://www.nde-ed.org/Physics/Magnetism/MagneticMatls.xhtml
73. W. S. Bainbridge and M. C. Roco, Eds., Managing nano-bio-info-cogno innovations. Dordrecht: Springer Netherlands, 2006. https://doi.org/10.1007/1-4020-4107-1
74. S. Angerbauer, T. Pankratz, F. Enzenhofer, A. Springer, R. Khanzadeh, and W. Haselmayr, “Molecular nano neural networks (M3N): In-body intelligence for the IoBNT,” in ICC 2024-IEEE International Conference on Communications, IEEE, 2024, pp. 4819–4824. Accessed: Jun. 14, 2025. [Online]. Available: https://ieeexplore.ieee.org/abstract/document/10622358/
75. C. Lipps, “IoBNT - Internet of Bio-Nano-Things.” Accessed: Jun. 14, 2025. [Online]. Available: https://www.dfki.de/en/web/research/projects-and-publications/project/iobnt
76. D. Santiago, “A Quantum Timing Change: Codon Energetics,” Mar. 11, 2025, Preprints: 2025030548. https://doi.org/10.20944/preprints202503.0548.v2.
77. R. P. Feynman, “The Feynman Lectures on Physics.” Accessed: Sep. 17, 2018. [Online]. Available: http://www.feynmanlectures.caltech.edu/I_01.html
78. U. Klein, “Quantizing Galilean spacetime: a reconstruction of Maxwell’s equations in empty space,” Quantum Stud. Math. Found., vol. 11, no. 3, pp. 717–737, Oct. 2024, https://doi.org/10.1007/s40509-024-00345-4.
79. H. Ueda, “The secret life of an electromagnon,” Lightsources.org. Accessed: Apr. 29, 2025. [Online]. Available: https://lightsources.org/2023/11/28/the-secret-life-of-an-electromagnon/
80. J. W. Oller, “The human language capacity and physics: eleven dimensions of empirical reality proved by construction,” Open Access Library Journal, vol. 10, no. 11, Art. no. 11, Nov. 2023, https://doi.org/10.4236/oalib.1110880.
81. R. Feynman, “The Feynman Lectures on Physics Vol. II Ch. 34: The Magnetism of Matter.” Accessed: Apr. 29, 2025. [Online]. Available: https://www.feynmanlectures.caltech.edu/II_34.html
82. Wikipedia, “Battelle Memorial Institute,” Wikipedia. Mar. 13, 2025. Accessed: May 02, 2025. [Online]. Available: https://en.wikipedia.org/w/index.php?title=Battelle_Memorial_Institute&oldid=1280216836
83. Battelle, “Battelle, IBM, Merck join UPMC’s effort to produce vaccines.” Accessed: Apr. 11, 2025. [Online]. Available: https://www.domain-b.com/industry/battelle-ibm-merck-join-upmc-s-effort-to-produce-vaccines
84. “Battelle Neuro Team Advances to Phase II of DARPA N3 Program| Battelle Press Release,” Default. Accessed: Jan. 02, 2025. [Online]. Available: https://www.battelle.org/insights/newsroom/press-release-details/battelle-neuro-team-advances-to-phase-ii-of-darpa-n3-program
85. James Giordano, “DARPA’s N3: The Future of Non-Surgical Brain Interfaces,” Institute for Biodefense Research. Accessed: Jan. 02, 2025. [Online]. Available: https://biodefenseresearch.org/darpas-n3-the-future-of-non-surgical-brain-interfaces/
86. E. Staff, “Magnetism Plays Key Roles in DARPA Research to Develop Brain-Machine Interface without Surgery -.” Accessed: Jan. 02, 2025. [Online]. Available: https://magneticsmag.com/magnetism-plays-key-roles-in-darpa-research-to-develop-brain-machine-interface-without-surgery/
87. F. Deruelle, “The different sources of electromagnetic fields: Dangers are not limited to physical health,” Electromagnetic Biology and Medicine, vol. 39, no. 2, pp. 166–175, Apr. 2020, https://doi.org/10.1080/15368378.2020.1737811.
88. F. Deruelle, “The pharmaceutical industry is dangerous to health. Further proof with COVID-19,” Surg Neurol Int, vol. 13, p. 475, 2022, https://doi.org/10.25259/SNI_377_2022.
89. F. Deruelle, “Microwave radiofrequencies, 5G, 6G, graphene nanomaterials: Technologies used in neurological warfare,” Surgical Neurology International, vol. 15, no. 439, p. 1, 2024, https://doi.org/HTTPS://DOI.ORG/10.25259/SNI_731_2024.
90. H. Huelss, “Norms are what machines make of them: autonomous weapons systems and the normative implications of human-machine interactions,” Int. Polit. Sociol., vol. 14, no. 2, pp. 111–128, Jun. 2020, https://doi.org/10.1093/ips/olz023.
91. H. Huelss, “Transcending the fog of war? US military ‘AI’, vision, and the emergent post-scopic regime,” Eur. J. Int. Secur., May 2024, https://doi.org/10.1017/eis.2024.21.
92. D. A. Hughes, “COVID-19,” Psychological Operations, and the War for Technocracy: Volume 1. Cham: Springer International Publishing, 2024. https://doi.org/10.1007/978-3-031-41850-1.
93. P. M. Wood, D. A. Hughes, D. Broudy, L. Johnson, C. A. Fitts, and Technocracy News & Trends, OMNIWAR: Battle for the Brain Symposium, (Apr. 26, 2025). Accessed: May 02, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=6A_medaFwV4
94. D. Hughes, V. Kyrie, and D. Broudy, “COVID-19 - Mass Formation or Mass Atrocity?,” Unlimited Hangout. Accessed: Jun. 15, 2025. [Online]. Available: https://unlimitedhangout.com/2022/11/investigative-reports/covid-19-mass-formation-or-mass-atrocity/
95. N. Hulscher, R. Hodkinson, W. Makis, and P. A. McCullough, “Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis,” ESC Heart Failure, vol. n/a, no. n/a, Jan. 2024, https://doi.org/10.1002/ehf2.14680.
96. S. Mansanguan, P. Charunwatthana, W. Piyaphanee, W. Dechkhajorn, A. Poolcharoen, and C. Mansanguan, “Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents,” Tropical Medicine and Infectious Disease, vol. 7, no. 8, Art. no. 8, Aug. 2022, https://doi.org/10.3390/tropicalmed7080196.
97. Y. R. Patel, D. W. Louis, M. Atalay, S. Agarwal, and N. R. Shah, “Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series,” Journal of Cardiovascular Magnetic Resonance, vol. 23, no. 1, p. 101, Sep. 2021, https://doi.org/10.1186/s12968-021-00795-4.
98. C. L. F. Sun, E. Jaffe, and R. Levi, “Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave,” Sci Rep, vol. 12, no. 1, p. 6978, Apr. 2022, https://doi.org/10.1038/s41598-022-10928-z.
99. A. M. Kyriakopoulos, G. Nigh, P. A. McCullough, and S. Seneff, “Autoimmune and neoplastic outcomes after the mRNA vaccination: the role of T regulatory cell responses,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1395–1433, Oct. 2024, https://doi.org/10.56098/16j4nf05.
100. P. I. Parry et al., “‘Spikeopathy’: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA,” Biomedicines, vol. 11, no. 8, Art. no. 8, Aug. 2023, https://doi.org/10.3390/biomedicines11082287.
101. A. M. Kyriakopoulos and S. Seneff, “Pathology Deterioration in a Pure β-zero Thalassemia Heterozygote After mRNA COVID-19 Vaccination: A Case Report and Literature Review,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1245–1274, Aug. 2024, https://doi.org/10.56098/y768gc33.
102. J.-C. Pérez, C. Moret-Chalmin, and L. Montagnier, “Emergence of a new Creutzfeldt-Jakob disease: 26 cases of the human version of mad-cow disease, a few days after a COVID-19 injection,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 1, pp. 727–770, 2023, https://doi.org/https://doi.org/10.56098/ijvtpr.v3i1.66.
103. S. Pelech and C. A. Shaw, Down the COVID-19 Rabbit Hole. Skyhorse Publishing, 2024. [Online]. Available: https://www.amazon.com/Down-COVID-19-Rabbit-Hole-Independent/dp/1510779590
104. “Cancer rising in kids,” Mar. 26, 2025. [Online]. Available: https://x.com/tuckercarlson/status/1904941620283253060?s=12